- Home
- DGICA vs PRME Comparison
DGICA vs PRME Comparison
Compare DGICA & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DGICA | PRME |
|---|---|---|
| Founded | 1986 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 711.9M | 666.1M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | DGICA | PRME |
|---|---|---|
| Price | $19.27 | $4.11 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $21.00 | $6.42 |
| AVG Volume (30 Days) | 101.8K | ★ 3.7M |
| Earning Date | 02-19-2026 | 02-27-2026 |
| Dividend Yield | ★ 3.68% | N/A |
| EPS Growth | ★ 219.91 | N/A |
| EPS | ★ 2.38 | N/A |
| Revenue | ★ $987,826,105.00 | $5,977,000.00 |
| Revenue This Year | $2.26 | $111.80 |
| Revenue Next Year | $3.46 | N/A |
| P/E Ratio | $8.34 | ★ N/A |
| Revenue Growth | 0.89 | ★ 647.13 |
| 52 Week Low | $14.17 | $1.11 |
| 52 Week High | $21.12 | $6.94 |
Technical Indicators
Market Signals| Indicator | DGICA | PRME |
|---|---|---|
| Relative Strength Index (RSI) | 39.40 | 57.24 |
| Support Level | $19.11 | $3.29 |
| Resistance Level | $20.30 | $4.17 |
| Average True Range (ATR) | 0.45 | 0.23 |
| MACD | -0.08 | 0.09 |
| Stochastic Oscillator | 10.69 | 78.16 |
Price Performance
Historical ComparisonAbout DGICA Donegal Group Inc.
Donegal Group Inc is an insurance holding company that offers businesses and individuals personal and commercial lines of property and casualty insurance. The company's reportable segments are its Investment function, Personal lines of insurance, and Commercial lines of insurance. Personal lines products consist mainly of homeowners and private passenger automobile policies. The Commercial lines products of its insurance subsidiaries consist mainly of commercial automobile, commercial multi-peril, and workers' compensation policies. The group mainly operates in the United States.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.